Tumor-suppressor p53 specifically binds to miR-29c-3p and reduces ADAM12 expression in hepatocellular carcinoma
- 16 July 2022
- journal article
- research article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 55 (3) , 412-421
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Critical Roles of p53 in Epithelial-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma CellsPLOS ONE, 2013
- MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinomaOncogene, 2013
- MicroRNA-22 is down-regulated in hepatitis B virus-related hepatocellular carcinomaBiomedicine & Pharmacotherapy, 2013
- MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinomaCancer Letters, 2013
- A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasionOncogene, 2011
- Biomarker to distinguish hepatocellular carcinoma from cholangiocarcinoma by serum a disintegrin and metalloprotease 12Archives of Medical Science, 2011
- Transforming Growth Factor-β1–Mediated Activation of NF-κB Contributes to Enhanced ADAM-12 Expression in Mammary Carcinoma CellsMolecular Cancer Research, 2010
- miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalitiesLeukemia, 2009
- p53 in health and diseaseNature Reviews Molecular Cell Biology, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001